Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

"Lung cancer: Comparable patterns of failure between SBRT, lobectomy or pneumonectomy for stage I NSCLC." ScienceDaily. www.sciencedaily.com / releases / 2013 / 01 / 130115124526.htm (accessed ...

About 2.5 million new lung cancer cases were diagnosed worldwide in 2022 – an increase of 300,000 since 2020.

What is the iron lung? The iron lung was a large, cylindrical unit (measuring up to six feet in length) that functioned as a respirator to help patients who couldn’t breathe on their own.

Additionally, median PFS was improved from 5.5 months on the sorafenib alone treatment arm (95% CI 3.4–6.3) to 9.2 months on the SBRT with sorafenib treatment arm (7.5–11.9) (HR, 0.55, 95% CI ...

Stereotactic body radiotherapy (SBRT) compared with traditional radiation in patients with localized prostate cancer has been found to be noninferior, meaning it works just as well. The phase 3 study, ...

Researchers analyzed data from the Dutch Lung Cancer Audit for Radiotherapy database, which included 7279 patients with stage I NSCLC who received SBRT between January 2017 and December 2021.

Stereotactic body radiation therapy (SBRT) is a highly precise cancer treatment that delivers high doses of radiation to tumours while minimizing damage to healthy tissues. It's often used for ...

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all cases. It develops when abnormal lung cells grow uncontrollably, forming a tumor.

In October 2022, I was diagnosed with stage 4 lung cancer, as there was a small lesion on my spine. The cancer had spread. I was in shock and denial, but also in survival mode.

Researchers have released new guidelines for stereotactic body radiotherapy (SBRT) in patients with primary renal cell carcinoma (RCC), based on results of a systematic review. The review and ...